Vanda Pharmaceuticals Inc.
METHODS FOR THE ADMINISTRATION OF ILOPERIDONE
Last updated:
Abstract:
The present invention relates to methods for the identification of genetic polymorphisms that may be associated with a risk for QT prolongation after treatment with iloperidone and related methods of administering iloperidone to patients with such polymorphisms.
Status:
Application
Type:
Utility
Filling date:
8 Apr 2022
Issue date:
18 Aug 2022